Cited by 257Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and Treatments

Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons

Open access
Dobi, Alice, Margolis, Elyssa B., Wang, Hui-Ling, Harvey, Brandon K., Morales, Marisela·2010·The Journal of Neuroscience

Abstract

The ventral tegmental area (VTA) contributes to reward and motivation signaling. In addition to the well established populations of dopamine (DA) or GABA VTA neurons, glutamatergic neurons were recently discovered in the VTA. These glutamatergic neurons express the vesicular glutamate transporter 2, VGluT2. To investigate whether VTA glutamatergic neurons establish local synapses, we tagged axon terminals from resident VTA neurons by intra-VTA injection of Phaseolus vulgaris leucoagglutinin (PHA-L) or an adeno-associated virus encoding wheat germ agglutinin (WGA) and by immunoelectron microscopy determined the presence of VGluT2 in PHA-L- or WGA-positive terminals. We found that PHA-L- or WGA-positive terminals from tagged VTA cells made asymmetric or symmetric synapses within the VTA. VGluT2 immunoreactivity was detected in the vast majority of PHA-L- or WGA-positive terminals forming asymmetric synapses. These results indicate that both VTA glutamatergic and nonglutamatergic (likely GABAergic) neurons establish local synapses. To examine the possible DAergic nature of postsynaptic targets of VTA glutamatergic neurons, we did triple immunolabeling with antibodies against VGluT2, tyrosine hydroxylase (TH), and PHA-L. From triple-labeled tissue, we found that double-labeled PHA-L (+)/VGluT2 (+) axon terminals formed synaptic contacts on dendrites of both TH-positive and TH-negative cells. Consistent with these anatomical observations, in whole-cell slice recordings of VTA neurons we observed that blocking action potential activity significantly decreased the frequency of synaptic glutamatergic events in DAergic and non-DAergic neurons. These observations indicate that resident VTA glutamatergic neurons are likely to affect both DAergic and non-DAergic neurotransmission arising from the VTA.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.3884-09.2010

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • 60% of VTA efferent projections are dopaminergic, and VTA also contains glutamatergic and GABAergic neurons.

    “A total 60% of efferent projections of the VTA are dopaminergic, although it contains glutamatergic and GABAergic neurons also (Dobi et al., 2010).”

    From Circuit Mechanisms of Reward, Anhedonia, and Depression (2019) · cites this paper as Dobi et al., 2010

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 69 · Cited by 257

Authors
Dobi, A., Margolis, E. B., Wang, H.-L., Harvey, B. K., & Morales, M.
Affiliations
  • National Institute on Drug Abuse (US)
  • University of California, San Francisco (US)
Corresponding author
Morales, Marisela
Venue
The Journal of Neuroscience
Published
2010-01-06
Volume
30
Issue
1
Pages
218-229
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2115602937
Cited by
257
References
69
Citations by year
2026: 3 · 2025: 9 · 2024: 15 · 2023: 13 · 2022: 15 · 2021: 13 · 2020: 30 · 2019: 16 · 2018: 15 · 2017: 12 · 2016: 18 · 2015: 18 · 2014: 19 · 2013: 14 · 2012: 23
FWCI
7.88
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • University of California, San Francisco
  • National Institute on Drug Abuse (Z01DA000509)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
ventral tegmental area, glutamatergic neurons, vesicular glutamate transporter 2, dopaminergic neurons, GABAergic neurons, axon terminals, asymmetric synapses, tyrosine hydroxylase, glutamatergic neurotransmission, reward and motivation
MeSH terms
Animals, Dopamine, Male, Neurons, Synapses, Rats, Sprague-Dawley, Ventral Tegmental Area, Presynaptic Terminals, Glutamic Acid, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review